RT30 + GLOW70 — Bundle
Triple Agonist 30mg + CP-3 Composite 70mg · 2 Vials, 2 Cartridges or 2 Ready-to-Use Pens
Two research compounds, one price. This bundle pairs RT30 from our Metabolic range with GLOW70 from our Tissue & Recovery range — the same products we sell individually, in the format you choose: two vials, two cartridges for a re-usable pen, or two ready-to-use disposable pens.
| In the bundle | 1 × RT30 and 1 × GLOW70, in your choice of format |
| RT30 | Triple GIP / GLP-1 / glucagon receptor agonist · 30mg |
| GLOW70 | GHK-Cu / BPC-157 / TB-500 composite · 70mg |
| Formats | Vials — lyophilised powder Cartridges — pre-filled, for a re-usable pen (pen sold separately) Ready-to-use disposable pens — fully pre-loaded and self-contained |
Bundle prices
| Format | Bundle price | Bought separately | You save |
|---|---|---|---|
| 2 Vials | £139.99 | £84.99 + £59.99 = £144.98 | £4.99 |
| 2 Cartridges for Re-usable Pen | £149.99 | £89.99 + £69.99 = £159.98 | £9.99 |
| 2 Ready-to-Use Disposable Pens | £169.99 | £99.99 + £79.99 = £179.98 | £9.99 |
About the Triple Agonist
This compound is a synthetic peptide combining agonist activity at GIP, GLP-1, and glucagon receptors — a triple mechanism that has generated substantial interest across the metabolic research community for its broader receptor engagement compared to single- or dual-agonist compounds. View RT30 →
About the GLOW70 CP-3 Composite
GLOW70 combines GHK-Cu, BPC-157 and TB-500 (a Thymosin Beta-4 fragment) in a single preparation. Each constituent has been studied independently in the published literature, for extracellular matrix and copper-dependent enzyme activity, growth factor signalling, and cytoskeletal regulation respectively. View GLOW70 →
For laboratory research use only. Not for human or veterinary use, and not for human consumption. Supplied exclusively to verified BioCompounds UK account holders for in-vitro and analytical research purposes.








Reviews
There are no reviews yet